Evidence map›Paper›PMID 26078663›Full record

ArticleTurk pediatri arsivi2014

Association of familial Mediterranean fever in Turkish children with inflammatory bowel disease.

Ömer Faruk Beşer, Fügen Çullu Çokuğraş, Tufan Kutlu, Ethem Erginöz, Didem Gülcü, Özgür Kasapçopur, Tülay Erkan

Open access · bronzeAbstract read
In one paragraph

Article in Turk pediatri arsivi, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Familial Mediterranean Fever in Childhood.Turkish archives of pediatrics · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Familial Mediterranean Fever Mutation Analysis in Pediatric Patients With İnflammatory Bowel Disease: A Multicenter Study.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ömer Faruk BeşerDepartment of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Fügen Çullu ÇokuğraşDepartment of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Tufan KutluDepartment of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Ethem ErginözDepartment of Public Health, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Didem GülcüDepartment of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Özgür KasapçopurDepartment of Pediatrics, Division of Pediatric Rheumatology, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Tülay ErkanDepartment of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Istanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimFamilial Mediterranean fever (FMF) and inflammatory bowel disease (IBD) carry similar clinical and biological properties. Both are characterized with chronic inflammation attacks and neutrophil migration and impaired apoptosis mechanism are present in the areas of damage in both conditions. In our study, we aimed to determine the frequency of association of FMF in patients with IBD, to compare the demographic, clinical, laboratory and treatment response properties in these patients with the ones in other IBD patients and to determine association of FMF especially in treatment-resistant patients. MATERIAL AND

methodsFifty-three patients who were being followed up with a diagnosis of IBD aged between 0 and 18 years were included in the study. The patient group included the patients who were diagnosed with IBD according to clinical, serological, endoscopic and histopathological criteria, who were being followed up and whose therapies were continuing. Genetic analysis in terms of MEFV gene mutations was performed in all patients with a diagnosis of IBD. Acute phase reactants, complete blood count, immunoglobulin levels, stool analysis, "perinuclear anti-neutrophil cytoplasmic antibodies" (pANCA) and "anti-Saccharomyces cerevisiae antibodies" (ASCA) were studied at the time of diagnosis. The diagnosis of FMF was made according to detailed history, physical examination findings, laboratory tests and the results of genetic analyses in terms of MEFV gene mutations in accordance with the criteria defined in 2009.

resultsWe found that FMF accompanied in 14 (26.4%) of the patients who had a diagnosis of IBD. 3 of these 14 patients in whom FMF accompanied were being followed up with a diagnosis of Crohn disease and 11 were being followed up with a diagnosis of ulcerative colitis. All of these patients had MEFV gene mutation. These mutations included M694V (50%), K695R (21.4%), M680I (14.3%) and R202Q (14.3%) in order of frequency. When the laboratory data were compared between the patients who had a diagnosis of IBD alone and who had a diagnosis of IBD plus FMF, it was observed that the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) values were statistically significantly higher in the IBD+FMF group.

conclusionsFMF is a common condition in the Turkish population and M694V mutation is found most commonly. In our study, this status did not change in cases where FMF accompanied IBD, but K695R mutation was found more frequently compared to FMF alone. We think that it should be kept in mind that other inflammatory conditions including mainly FMF may accompany IBD, if a case of IBD does not have an expected course or is resistant to treatment.

Indexed as

Familial Mediterranean feverinflammatory bowel diseaseMEFV

Identifiers

PMID26078663
PMCPMC4462301
OpenAlexW2334302717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.